Import/Export Declaration for List I and List II Chemicals

Forms and Documents

Document Name	Status
1117-0023 Supporting Statement DEA Form 486-486A (Final) 8-2-17.rtf Supporting Statement A	2017-08-02
Create Screenshot New DEA 486a (Import).pdf Supplementary Document	2017-06-16
Create Screenshot New DEA 486a (Import).pdf Supplementary Document	2017-06-16
21 U.S.C. 830.doc Supplementary Document	2008-11-20

IC Document Collections

IC ID	Document Title	Status
12323	Import/Export Declaration for List I and List II Chemicals (Year) Other-DEA 486 (Export) Web Application	Modified

ICR Details

OMB Control No: 1117-0023	ICR Reference No: 201708-1117-003
Status: Historical Active	Previous ICR Reference No: 201706-1117-001
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: Import/Export Declaration for List I and List II Chemicals
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 09/26/2017
	Date Received in OIRA: 08/02/2017
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	09/30/2020	36 Months From Approved	11/30/2019
Responses	13,661	0	13,661
Time Burden (Hours)	4,422	0	4,422
Cost Burden (Dollars)	242,781	0	242,781

---

Abstract: The DEA import/export declarations (DEA Forms 486 and 486A), will be replaced with an electronic process. Upon receipt of a complete declaration through the Diversion Control Division secure network application, DEA will provide the importer or exporter with the notice of receipt that must then be filed with Custom Border Patrol as part of the CBP import or export filing through Automated Commercial Environment (ACE), or any successor system. DEA will also transmit the declaration information electronically to CBP so that customs officers can validate importations and exportations subject to DEA regulations. Because of the requirement that regulated persons submit reports of regulated transactions in Listed chemicals to the DEA, the DEA is requiring such domestic regulated transaction reports to be submitted through the DEA Diversion Control Division secure network application, in addition to import and export regulated transactions. Mandatory reporting requirements for domestic regulated transactions are included as part of this rule because it allows for the DEA to create, at one time, an efficient, streamlined reporting structure of regulated activities applicable to tableting and encapsulating machines. As part of the implementation of the International Trade Data System (ITDS), the DEA is mandating electronic filing of return information for any person who desires to import non-narcotic substances in schedules III, IV, and V or to export non-narcotic substances in schedules III and IV and any other substance in schedule V, to furnish a controlled substances import declaration/controlled substance export invoice on DEA Forms 486 and 486A

---

Authorizing Statute(s): US Code: 21 USC 971 Name of Law: ...importation and exportation of listed chemicals
  

Citations for New Statutory Requirements: PL: Pub.L. 109 - 177 721 Name of Law: Combat Methamphetamine Act

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
1117-AB41	Final or interim final rulemaking	81 FR 96992	12/30/2016

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 63576	09/15/2016
30-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 96992	12/30/2016
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Import/Export Declaration for List I and List II Chemicals (Year)	486, 486 (page 2), 486A, 486A (page 2)	Import/Export Declaration for List I and List II Chemicals ,   Import/Export Declaration for List I and List II Chemicals ,   Import Declaration for Ephedrine, Pseudoephedrine, and Phenylpropanolamine ,   Import Declaration for Ephedrine, Pseudoephedrine, and Phenylpropanolamine

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	13,661	13,661	0	0	0	0
Annual Time Burden (Hours)	4,422	4,422	0	0	0	0
Annual Cost Burden (Dollars)	242,781	242,781	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $515,721

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     Yes

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/02/2017

---